Stock MANGALAM MANGALAM DRUGS & ORGANICS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

News Mangalam Drugs & Organics Limited NSE India S.E.

Equities

MANGALAM

INE584F01014

Market Closed - NSE India S.E.
Other stock markets
 05:13:55 28/06/2024 pm IST 		5-day change 1st Jan Change
103.6 INR +0.81% Intraday chart for Mangalam Drugs & Organics Limited -2.50% +5.50%
16/03 Mangalam Drugs & Organics Limited agreed to acquire Shri JB Pharma LLP. CI
13/02 Mangalam Drugs & Organics Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Mangalam Drugs & Organics Limited agreed to acquire Shri JB Pharma LLP.
CI
Mangalam Drugs & Organics Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
CI
Mangalam Drugs & Organics Limited Reports Earnings Results for the Half Year Ended September 30, 2023
CI
Mangalam Drugs & Organics Limited Reports Earnings Results for the First Quarter Ended June 30, 2023
CI
Mangalam Drugs & Organics Limited Reports Earnings Results for the Full Year Ended March 31, 2023
CI
Mangalam Drugs & Organics Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023
CI
Mangalam Drugs & Organics Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022
CI
Mangalam Drugs & Organics Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022
CI
Mangalam Drugs & Organics Limited Reports Earnings Results for the First Quarter Ended June 30, 2022
CI
Mangalam Drugs & Organics Limited Reports Earnings Results for the Full Year Ended March 31, 2022
CI
Mangalam Drugs & Organics Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2022
CI
Mangalam Drugs & Organics Limited Announces Appointment of Shri Rakesh K. Milwani as an Additional Director (Non- Executive Non- Independent Director)
CI
Mangalam Drugs & Organics : Resignation
PU
Mangalam Drugs & Organics Limited Announces Executive Changes
CI
Mangalam Drugs & Organics Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021
CI
Mangalam Drugs & Organics Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021
CI
Mangalam Drugs & Organics Limited Announces Earnings Results for the First Quarter Ended June 30, 2021
CI
Mangalam Drugs & Organics : and Organics Commissions New Manufacturing Facility in Gujarat, India
MT
Mangalam Drugs & Organics Limited Provides Update on Setting-Up of New Intermediate Manufacturing Facility At Unit 1 Located in Vapi, Gujarat
CI
Mangalam Drugs & Organics' : Net Profit Plummets in Fiscal Q4; Shares Plunge 8%
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. MANGALAM Stock
  4. MANGALAM Stock
  5. News Mangalam Drugs & Organics Limited